Phenotypic and genotypic diagnosis of von Willebrand disease: A 2004 update

Seminars in Hematology

Volumn 42, Issue 1, 2005, Pages 15-28

  Schneppenheim, Reinhard ^a   Budde, Ulrich ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Arndt and Partner   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

CORRELATION ANALYSIS; DISEASE CLASSIFICATION; ELECTROPHORESIS; GENOTYPE; HUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; VON WILLEBRAND DISEASE;

EID: 12344262502     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2004.10.002     Document Type: Article

References (73)

1. Y. Fujimura, K. Titani, L.Z. Holland, S.R. Russell, J.R. Roberts, J.H. Elder von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib J Biol Chem 261 1986 381 385
2. E.F. Plow, M.D. Pierschbacher, E. Ruoslahti, G.A. Marguerie, M.H. Ginsberg The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets Proc Natl Acad Sci U S A 82 1985 8057 8061
3. P.A. Foster, C.A. Fulcher, T. Marti, K. Titani, T.S. Zimmerman A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor J Biol Chem 262 1987 8443 8446
4. F.I. Pareti, K. Niiya, J.M. McPherson, Z.M. Ruggeri Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III J Biol Chem 262 1987 13835 13841
5. H. Mohri, A. Yoshioka, T.S. Zimmerman, Z.M. Ruggeri Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites J Biol Chem 264 1989 17361 17367
6. Z.M. Ruggeri Platelet and von Willebrand factor interactions at the vessel wall Hamostaseologie 24 2004 1 11
7. H.J. Weiss, I.I. Sussman, L.W. Hoyer Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease J Clin Invest 60 1977 390 404
8. B.E. Fischer, G. Kramer, A. Mitterer, L. Grillberger, M. Reiter, W. Mundt Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII Thromb Res 84 1996 55 66
9. T.N. Mayadas, D.D. Wagner Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly Proc Natl Acad Sci U S A 89 1992 3531 3535
10. T. Marti, S.J. Rosselet, K. Titani, K.A. Walsh Identification of disulfide-bridged substructures within human von Willebrand factor Biochemistry 26 1987 8099 8109
11. R. Schneppenheim, J. Brassard, S. Krey, U. Budde, T.J. Kunicki, L. Holmberg Defective dimerization of von Willebrand factor subunits due to a Cys→Arg mutation in type IID von Willebrand disease Proc Natl Acad Sci U S A 93 1996 3581 3586
12. R. Schneppenheim, U. Budde, T. Obser, J. Brassard, K. Mainusch, Z.M. Ruggeri Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease Blood 97 2001 2059 2066
13. R. Schneppenheim, T. Obser, S. Schneppenheim, K. Mainusch, D. Angerhaus, U. Budde Von Willebrand disease type 2A with aberrant structure of individual oligomers is caused by mutations clustering in the von Willebrand factor D3 domain Blood 96 2000 566a (abstr)
14. C. Gaucher, J. Dieval, C. Mazurier Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease Blood 84 1994 1024 1030
15. R. Schneppenheim, K.B. Thomas, S. Krey, U. Budde, U. Jessat, A.H. Sutor Identification of a candidate missense mutation in a family with von Willebrand disease type IIC Hum Genet 95 1995 681 686
16. L. Holmberg, D. Karpman, C. Isaksson, A.C. Kristoffersson, S. Lethagen, R. Schneppenheim Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's disease Thromb Haemost 79 1998 718 722
17. S. Allen, A.M. Abuzenadah, J. Hinks, J.L. Blagg, T. Gursel, J. Ingerslev A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion Blood 96 2000 560 568
18. J.B. Rosenberg, S.L. Haberichter, M.A. Jozwiak, E.A. Vokac, P.A. Kroner, S.A. Fahs The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF Blood 100 2002 1699 1706
19. Z.M. Ruggeri, F.I. Pareti, P.M. Mannucci, N. Ciavarella, T.S. Zimmerman Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease N Engl J Med 302 1980 1047 1051
20. A. Casonato, M.T. Sartori, A. Bertomoro, T. Fede, F. Vasoin, A. Girolami Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease Blood Coagul Fibrinolysis 2 1991 33 40
21. A. Casonato, M.T. Sartori, L. de Marco, A. Girolami 1-Desamino-8-D- arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease Shortening of bleeding time and induction of a variable pseudothrombocytopenia Thromb Haemost 64 1900 117 120
22. M. Donner, A.C. Kristoffersson, H. Lenk, E. Scheibel, B. Dahlback, I.M. Nilsson Type IIB von Willebrand's disease Gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden Br J Haematol 82 1992 58 65
23. M. Nishino, J.P. Girma, C. Rothschild, E. Fressinaud, D. Meyer New variant of von Willebrand disease with defective binding to factor VIII Blood 74 1989 1591 1599
24. E.A. von Willebrand Hereditär pseudohemofili Finska Lakaresallskapets Handlingar 672 1926 7 112
25. C. Gaucher, S. Jorieux, B. Mercier, D. Oufkir, C. Mazurier The "Normandy" variant of von Willebrand disease Characterization of a point mutation in the von Willebrand factor gene Blood 77 1991 1937 1941
26. P.M. Cacheris, W.C. Nichols, D. Ginsburg Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction J Biol Chem 266 1991 13499 13502
27. R. Schneppenheim, U. Budde, S. Krey, E. Drewke, F. Bergmann, E. Lechler Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1 Thromb Haemost 76 1996 598 602
28. R. Schneppenheim, H. Lenk, T. Obser, J. Oldenburg, F. Oyen, S. Schneppenheim Recombinant expression of mutations causing von Willebrand disease type Normandy Characterization of a combined defect of factor VIII binding and multimerization Thromb Haemost 92 2004 36 41
29. J.E. Sadler Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis A revised classification of von Willebrand disease Thromb Haemost 71 1994 520 525
30. A.S. Ribba, I. Loisel, J.M. Lavergne, I. Juhan-Vague, B. Obert, G. Cherel Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen Thromb Haemost 86 2001 848 854
31. R. Schneppenheim, T. Obser, E. Drewke, U. Gross-Wieltsch, F. Oyen, A.H. Sutor Isolated molecular defects of von Willebrand factor binding to collagen do not correlate with bleeding symptoms Blood 98 2001 165 (abstr)
32. P.M. Mannucci, R. Lombardi, G. Castaman, J.A. Dent, A. Lattuada, F. Rodeghiero von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers Blood 71 1988 65 70
33. A. Casonato, E. Pontara, F. Sartorello, M.G. Cattini, M.T. Sartori, R. Padrini Reduced von Willebrand factor survival in type Vicenza von Willebrand disease Blood 99 2002 180 184
34. P.J. Lenting, E. Westein, V. Terraube, A.S. Ribba, E.G. Huizinga, D. Meyer An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation J Biol Chem 279 2004 12102 12109
35. Z.M. Rugggeri Classification of von Willebrand disease M. Verstraete J. Vermylen R. Lijnen J. Arnout Thrombosis and Haemostasis 1987 Leuven University Press Leuven, The Netherlands 419 445
36. F. Rodeghiero, G. Castaman Congenital von Willebrand disease type I Definition, phenotypes, clinical and laboratory assessment Baillieres Clin Haematol 14 2001 321 335
37. J.E. Sadler Von Willebrand disease type 1 A diagnosis in search of a disease Blood 101 2003 2089 2093
38. F. Rodeghiero, G.C. Castaman, A. Tosetto, A. Lattuada, P.M. Mannucci Platelet von Willebrand factor assay--Results using 2 methods for platelet lysis Thromb Res 59 1990 259 267
39. A.J. Vlot, E.P. Mauser Bunschoten, A.G. Zarkova, E. Haan, C.L. Kruitwagen, J.J. Sixma The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A Thromb Haemost 83 2000 65 69
40. S. Kinoshita, J. Harrison, J. Lazerson, C.F. Abildgaard A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII-related antigen (type IID) Blood 63 1984 1369 1371
41. Z.M. Ruggeri, I.M. Nilsson, R. Lombardi, L. Holmberg, T.S. Zimmerman Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC) J Clin Invest 70 1982 1124 1127
42. M. Ledford, I. Rabinowtz, J.E. Sadler New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance von Willebrand disease type IIC Miami Blood 82 1993 169 175
43. T.S. Zimmerman, J.A. Dent, Z.M. Ruggeri, L.H. Nannini Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID and IIE) J Clin Invest 77 1986 947 951
44. H.J. Weiss, I.I. Sussman A new von Willebrand variant (type I, New York) Increased ristocetin-induced palatelet aggregation and plasma von Willebrand factor containing the full range of multimers Blood 68 1986 149 156
45. L. Holmberg, E. Berntorp, M. Donner, I.M. Nilsson von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma Blood 68 1986 668 672
46. B. Zieger, U. Budde, U. Jessat, R. Zimmerman, M. Simon, R. Katzel New families with von Willebrand disease type 2M (Vicenza) Thromb Res 87 1987 57 64
47. C. Mazurier Von Willebrand disease masquerading as haemophilia A Thromb Haemost 67 1992 391 396
48. S. Jorieux, C. Gaucher, J. Goudemand, C. Mazurier A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization Blood 92 1998 4463 4670
49. S. Jorieux, E. Fressinaud, J. Goudemand, C. Gaucher, D. Meyer, C. Mazurier Conformational changes in the D′ domain of von Willebrand factor induced by CYS25 and CYS95 mutations lead to factor VIII binding defect and multimeric impairment Blood 95 2000 3139 3145
50. S. Allen, A.M. Abuzenadah, J.L. Blagg, J. Hinks, I.M. Nesbitt, A.C. Goodeve Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor Blood 95 2000 2000 2007
51. Z.P. Zhang, G. Falk, M. Blomback, N. Egberg, M. Anvret A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients Hum Mol Genet 1 1992 767 768
52. R. Schneppenheim, S. Krey, F. Bergmann, D. Bock, U. Budde, M. Lange Genetic heterogeneity of severe von Willebrand disease type III in the German population Hum Genet 94 1994 640 652
53. H. Gazda, U. Budde, S. Krey, R. Rokicka-Milewska, R. Schneppenheim Delta C in exon 18 of the von Willebrand factor gene is the most common mutation in patients with severe von Willebrand disease type 3 in Poland Blood 90 1997 3132 (abstr)
54. Z.M. Ruggeri, T.S. Zimmerman Variant von Willebrand's disease Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets J Clin Invest 65 1980 1318 1325
55. J.A. Dent, S.D. Berkowitz, J. Ware, C.K. Kasper, Z.M. Ruggeri Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor Proc Natl Acad Sci U S A 87 1990 6306 63010
56. A.M. Randi, I. Rabinowitz, D.J. Mancuso, P.M. Mannucci, J.E. Sadler Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences J Clin Invest 87 1991 1220 1226
57. M. Furlan, R. Robles, B. Lämmle Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis Blood 87 1996 4223 4234
58. H.M. Tsai Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion Blood 87 1996 4235 4244
59. M.S. Enayat, A.M. Guilliatt, G.K. Surdhar, P.V. Jenkins, K.J. Pasi, C.H. Toh Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region Identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease Blood 98 2001 674 680
60. A.M. Journet, S. Saffaripour, D.D. Wagner Requirement for both D domains of the propolypeptide in von Willebrand factor multimerization and storage Thromb Haemost 70 1993 1053 1057
61. J.C. Eikenboom, T. Matsushita, P.H. Reitsma, E.A. Tuley, G. Castaman, E. Briet Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor Blood 88 1996 2433 2441
62. S. Lethagen, C. Isaksson, C. Schaedel, L. Holmberg Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X) Thromb Haemost 88 2002 421 426
63. L. Baronciani, G. Cozzi, M.T. Canciani, F. Peyvandi, A. Srivastava, A.B. Federici Molecular defects in type 3 von Willebrand disease Updated results from 40 multiethnic patients Blood Cells Mol Dis 30 2003 264 270
64. Z. Dong, R.S. Thoma, D.L. Crimmins, D.W. McCourt, E.A. Tuley, J.E. Sadler Disulfide bonds required to assemble functional von Willebrand factor multimers J Biol Chem 269 1994 6753 6758
65. L. Holmberg, J.A. Dent, R. Schneppenheim, U. Budde, J. Ware, Z.M. Ruggeri von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure J Clin Invest 91 1993 2169 2177
66. R.A. Romijn, E. Westein, B. Bouma, M.E. Schiphorst, J.J. Sixma, P.J. Lenting Mapping the collagen-binding site in the von Willebrand factor-A3 domain J Biol Chem 278 2003 15035 15039
67. L. Hilbert, E. Fressinaud, A.S. Ribba, D. Meyer, C. Mazurier INSERM Network on Molecular Abnormalities in von Willebrand Disease Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor Thromb Haemost 87 2002 635 640
68. A. Casonato, E. Pontara, F. Sartorello, A. Bertomoro, C. Durante, A. Girolami Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization J Lab Clin Med 137 2001 70 76
69. C.A. Hillery, D.J. Mancuso, J.E. Sadler, J.W. Ponder, M.A. Jozwiak, P.A. Christopherson Type 2M von Willebrand disease F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets Blood 91 1998 1572 1581
70. M.H. Horellou, E. Baumelou, N. Sitbon, J.P. Marie, J. Conard, C. De Carbonniere's Quatre cas de deficit acquis en facteur Willebrand associés a une dysgubulinémie monoclonale Ann Med Intern 143 1983 707 712
71. J.L. Moake Thrombotic microangiopathies N Engl J Med 347 2002 589 600
72. K. Nishio, P.J. Anderson, X.L. Zheng, J.E. Sadler Binding of platelet glycoprotein Ib (α) to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13 Proc Natl Acad Sci U S A 101 2004 10578 10583
73. I.C. Nitu-Whalley, A. Ridell, C.A. Lee, K.J. Pasi, D. Owens, M.S. Enayat Identifications of type 2 von Willebrand disease in previously diagnosed type 1 patients A reappraisal using phenotypes, genotypes and molecular modelling Thromb Haemost 84 2000 998 1004